$ABBV

AI Analysis

Generated on May 11, 2026

AI Score
70/ 100
Hold$ABBV

AbbVie Inc.

$ABBVNYSEHealthcareMega-Cap

AbbVie is a biopharmaceutical company focused on immunology (Skyrizi, Rinvoq), oncology, neuroscience, and aesthetics (Botox).

Market Cap
$330.0B
Revenue (TTM)
$56.3B
+4.0%
Net Income (TTM)
$5.5B
-10.0%
EPS (TTM)
$3.12
P/E Ratio
58.0
Dividend Yield
3.5%
52-Week Range
$154-$212
Beta
0.62
Dimension Scores
Fundamental
68
Technical
62
Sentiment
72
Risk / Reward
70
Momentum
65
FundTechSentRiskMome
Financial Health
Profitability
73moderate
Growth
68moderate
Liquidity
78strong
Solvency
70strong
Efficiency
66strong

Valuation, technical analysis, investment thesis, risk assessment and more for $ABBV

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.